Lotus Eye Hospital FY26 net profit falls 89% to ₹8.04 lakh

1 min read     Updated on 06 Jun 2026, 03:06 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Lotus Eye Hospital and Institute Limited reported an 89.1% decline in net profit to ₹8.04 lakh for FY26, despite revenue rising 8.4% to ₹5,371.41 lakh. The Board approved the audited financial results, which received an unmodified opinion from statutory auditors M/s. Anbarasu & Jalapathi. Additionally, the Board reappointed Mr. P Vishnu Adithan as Internal Auditor for FY 2026-27.

powered bylight_fuzz_icon
42284129

*this image is generated using AI for illustrative purposes only.

Lotus Eye Hospital and Institute Limited reported a sharp decline in profitability for the financial year ended March 31, 2026, with net profit falling 89.1% to ₹8.04 lakh from ₹73.93 lakh in the previous year. The company's revenue from operations rose 8.4% to ₹5,371.41 lakh from ₹4,956.25 lakh in FY25, driven by higher operational activity. Total income for the year increased to ₹5,489.03 lakh from ₹5,086.38 lakh in the prior year.

Financial Performance

The company's expenses outpaced revenue growth, impacting the bottom line. Total expenses for FY26 increased to ₹5,493.98 lakh from ₹4,949.10 lakh in the previous year. Finance costs surged significantly to ₹85.92 lakh from ₹35.50 lakh, while depreciation and amortization expenses rose to ₹374.94 lakh from ₹300.68 lakh. For the quarter ended March 31, 2026, the company reported a net loss of ₹31.95 lakh compared to a net profit of ₹25.23 lakh in the same quarter of the previous year.

Key Financial Metrics (FY26)

Metric FY26 (₹ in lakhs) FY25 (₹ in lakhs) Change
Revenue from operations 5,371.41 4,956.25 +8.4%
Total income 5,489.03 5,086.38 +7.9%
Total expenses 5,493.98 4,949.10 +11.0%
Net profit 8.04 73.93 -89.1%
Earnings per share (Basic) 0.04 0.36 -88.9%

Board Approvals and Auditor Report

The Board of Directors approved the standalone audited financial results for the quarter and year ended March 31, 2026, at a meeting held on May 26, 2026. M/s. Anbarasu & Jalapathi, Chartered Accountants, the statutory auditors, issued an audit report with an unmodified opinion. The report confirms that the financial results give a true and fair view in conformity with the recognition and measurement principles laid down in the Indian Accounting Standards (Ind AS).

Governance and Appointments

In addition to the financial results, the Board approved the reappointment of Mr. P Vishnu Adithan, Chartered Accountant, as the Internal Auditor of the company for the financial year 2026-27. The company operates in a single segment, "Eye Care related sales and services," and does not have any subsidiaries, associates, or joint ventures.

Historical Stock Returns for Lotus Eye Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
-5.38%+8.61%+1.31%+11.55%+67.14%+156.63%

What specific measures will management take to curb the surge in finance costs and depreciation expenses?

Is the 8.4% revenue growth sustainable given the recent quarterly net loss reported?

How does the company plan to improve operational efficiency to align expense growth with revenue?

Lotus Eye Hospital FY26 profit falls 89% on higher costs

1 min read     Updated on 27 May 2026, 07:45 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Lotus Eye Hospital And Institute Limited reported an 89% decline in FY26 net profit to ₹8.04 lakh, despite revenue from operations rising to ₹5,371.41 lakh. The surge in finance costs to ₹85.92 lakh and increased total expenses to ₹5,493.98 lakh pressured profitability, resulting in a net loss of ₹31.95 lakh for the quarter ended March 31, 2026. The Board approved the audited financial results on May 26, 2026, and reappointed Mr. P Vishnu Adithan as Internal Auditor for FY 2026-27.

powered bylight_fuzz_icon
40886544

*this image is generated using AI for illustrative purposes only.

Lotus Eye Hospital And Institute Limited reported a net profit of ₹8.04 lakh for the financial year ended March 31, 2026, a sharp decline of 89% from ₹73.93 lakh in the previous year. The company's revenue from operations for the year rose to ₹5,371.41 lakh from ₹4,956.25 lakh in FY25. For the quarter ended March 31, 2026, the company recorded a net loss of ₹31.95 lakh compared to a net profit of ₹25.23 lakh in the corresponding period of the previous year, primarily impacted by a surge in finance costs.

The Board of Directors, at its meeting held on May 26, 2026, approved the standalone audited financial results for the quarter and year ended March 31, 2026. M/s. Anbarasu & Jalapathi, Chartered Accountants, the statutory auditors, issued an audit report with an unmodified opinion. The board also reappointed Mr. P Vishnu Adithan, Chartered Accountant, as the Internal Auditor of the company for the financial year 2026-27.

Financial Performance

The company's total income for FY26 stood at ₹5,489.03 lakh, up from ₹5,086.38 lakh in the previous year. Total expenses increased to ₹5,493.98 lakh from ₹4,949.10 lakh. Finance costs for the year surged to ₹85.92 lakh from ₹35.50 lakh in FY25. The basic earnings per share (EPS) for the year dropped to ₹0.04 from ₹0.36 in the previous year.

Metric FY26 (₹ in lakh) FY25 (₹ in lakh)
Revenue from operations 5,371.41 4,956.25
Total Income 5,489.03 5,086.38
Total Expenses 5,493.98 4,949.10
Net Profit/(Loss) 8.04 73.93
Basic EPS (₹) 0.04 0.36

Operational Highlights

Exceptional items for the year amounted to a loss of ₹0.41 lakh, compared to a gain of ₹0.98 lakh in the previous year. The company's profit before tax for the year was a loss of ₹5.36 lakh, down from a profit of ₹138.26 lakh in FY25. The board meeting commenced at 05:15 PM and concluded at 06:00 PM on May 26, 2026. The intimation was made in compliance with Regulation 30, 33 and other applicable provisions of the SEBI (LODR) Regulations, 2015.

Pursuant to Regulation 47 of the SEBI (LODR) Regulations, 2015, the company published newspaper advertisements in the Business Standard (All India Edition) and The Tamil Hindu (Coimbatore Edition) on May 27, 2026, regarding the standalone audited financial results approved by the Board.

Historical Stock Returns for Lotus Eye Hospital

1 Day5 Days1 Month6 Months1 Year5 Years
-5.38%+8.61%+1.31%+11.55%+67.14%+156.63%

What specific measures will management take to curb the surging finance costs that eroded profitability?

Will the company consider raising capital or restructuring debt to improve its balance sheet efficiency?

How does the company plan to translate the growth in revenue into improved net profit margins in the coming fiscal year?

More News on Lotus Eye Hospital

1 Year Returns:+67.14%